6 line items for cyclobenzaprine tablets. Awarded for a base year of 6/3/2025 to 6/2/2026 with 4 one-year option periods.
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 36E79725D0018
- Awardee
-
Exelan Pharmaceuticals Inc. UEI FYZXNHSQTMG8
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- 6505--Cyclobenzaprine Tablets (VA-25-00015093) Pre-Solicitation · 36E79725R0009 · Posted Dec 2, 2024
- Last date to order 71% complete
- IDV ceiling
- $7,656,786.70
- Award type
- Single award
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 6 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Department of Veterans Affairs National Acquisition Center awarded a single-award indefinite-delivery contract to Exelan Pharmaceuticals Inc. for Cyclobenzaprine tablets with a ceiling of $7,656,786.70 on June 3, 2025.
The contract covers six line items for Cyclobenzaprine tablets under NAICS code 325412 (Pharmaceutical Preparation Manufacturing) and PSC code 6505 (Drugs and Biologicals). Performance occurs at Exelan's primary manufacturing and distribution facility in Boca Raton, Florida, with secondary performance locations in Cary, North Carolina; Summit, New Jersey; and Ottawa, Ontario, Canada, as well as other designated federal delivery locations specified by contracting agencies.
The procurement stemmed from a December 2024 pre-solicitation for Cyclobenzaprine HCL tablets targeting multiple federal agencies, including the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The solicitation required offerors to provide an uninterrupted supply of the medication in six package sizes (30, 60, 90, 180, 270, and either 500 or 1000 tablets per bottle) with child-proof safety caps and minimum 120cc volume bottles. Annual usage estimates ranged from 5,388 to 252,863 bottles across package sizes.
The performance period runs from June 3, 2025 to June 2, 2026 as the base year, with four one-year option periods extending potential performance through June 2, 2027. The contract was modified to implement Executive Order 14398 DEI discrimination compliance provisions as incorporated into national contract 36E79725D0018.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Add Subcontract Plan | $0 | |
| Add Subcontract Plan | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79725D0018?
36E79725D0018 was awarded to Exelan Pharmaceuticals Inc. by National Acquisition Center (Headquarters) on June 3, 2025.
How much is contract 36E79725D0018 worth?
36E79725D0018's own ceiling is $7,656,787.
Who can order from contract 36E79725D0018?
36E79725D0018 is a single award indefinite delivery contract.
Was contract 36E79725D0018 competed?
The extent of competition for 36E79725D0018 was full and open competition. The government received 6 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV